LifeSci Biotechnology Products Index
LifeSci Biotechnology Clinical Trials Index
The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 18, 2023. All positions will be equally weighted, with weights determined as of the closing prices on Thursday, December 14, 2023. The preliminary changes are summarized below.
LifeSci Biotechnology Clinical Trials Index (107 components as adjusted)
Additions (17 stocks):
ALPN, APGE, BEAM, BLTE, CABA, MGNX, NMRA, OLMA, ORIC, RYZB, SANA, SLNO, SLRN, SRRK, SYRE, TNGX, VERA
Deletions (21 stocks):
ABUS, ALDX, ARQT, ATAI, AVIR, BTAI, CERE, DSGN, ERAS, EWTX, FATE, FGEN, KOD, MCRB, MRSN, MRTX,